semaglutide level 3 weight loss dosage chart Rybelsus (semaglutide): Uses, Side Effects,

Other medications in this class include: Wegovy (semaglutide) - Same active ingredient as Ozempic, but FDA-approved for weight loss Mounjaro/Zepbound (tirzepatide) - Dual-action medication approved for diabetes (Mounjaro) and weight loss (Zepbound) Trulicity (dulaglutide) - Weekly injection for type 2 diabetes Victoza/Saxenda (liraglutide) - Available for diabetes (Victoza) and weight loss (Saxenda) Bydureon (exenatide) - Weekly injection, older medication in this class All of these work similarly by mimicking natural hormones that control blood sugar and appetite, though they may have different dosing schedules and approved uses.

These effects are not necessarily direct results of semaglutides action, but rather secondary effects due to changes in blood sugar control, hydration, or appetite

Our medically supervised weight loss injections are designed for adults with a BMI of 30 or higher, or 27 and above with weight-related health conditions such as high blood pressure, sleep apnea or diabetes

Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics

(2.3) Dosage Forms and Strengths Injection (3): o 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL, or 7.2 mg/0.75 mL (WEGOVY HD) in a single-dose pen o 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, or 2.4 mg/0.75 mL in a single-dose syringe o 9.6 mg/3 mL (3.2 mg/mL) solution in a single-patient-use pen (WEGOVY FlexTouch) that delivers four 2.4 mg/0.75 mL doses Tablets: 1.5 mg, 4 mg, 9 mg and 25 mg (3) Contraindications Warnings and Precautions Acute Pancreatitis: Has been observed in patients treated with GLP-1 receptor agonists, including WEGOVY